|
US4444887A
(en)
|
1979-12-10 |
1984-04-24 |
Sloan-Kettering Institute |
Process for making human antibody producing B-lymphocytes
|
|
US4716111A
(en)
|
1982-08-11 |
1987-12-29 |
Trustees Of Boston University |
Process for producing human antibodies
|
|
US5225539A
(en)
|
1986-03-27 |
1993-07-06 |
Medical Research Council |
Recombinant altered antibodies and methods of making altered antibodies
|
|
GB8607679D0
(en)
|
1986-03-27 |
1986-04-30 |
Winter G P |
Recombinant dna product
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
US5359078A
(en)
|
1989-05-19 |
1994-10-25 |
The United States Of America As Represented By The Department Of Health And Human Services |
Signal transduction inhibitor compounds
|
|
US5225347A
(en)
|
1989-09-25 |
1993-07-06 |
Innovir Laboratories, Inc. |
Therapeutic ribozyme compositions and expression vectors
|
|
GB8928874D0
(en)
|
1989-12-21 |
1990-02-28 |
Celltech Ltd |
Humanised antibodies
|
|
EP1690935A3
(en)
|
1990-01-12 |
2008-07-30 |
Abgenix, Inc. |
Generation of xenogeneic antibodies
|
|
US5141851A
(en)
|
1990-04-18 |
1992-08-25 |
Board Of Regents, The University Of Texas System |
Isolated farnesyl protein transferase enzyme
|
|
US5420245A
(en)
|
1990-04-18 |
1995-05-30 |
Board Of Regents, The University Of Texas |
Tetrapeptide-based inhibitors of farnesyl transferase
|
|
US5401629A
(en)
|
1990-08-07 |
1995-03-28 |
The Salk Institute Biotechnology/Industrial Associates, Inc. |
Assay methods and compositions useful for measuring the transduction of an intracellular signal
|
|
DE69233482T2
(de)
|
1991-05-17 |
2006-01-12 |
Merck & Co., Inc. |
Verfahren zur Verminderung der Immunogenität der variablen Antikörperdomänen
|
|
US5502224A
(en)
|
1991-06-04 |
1996-03-26 |
Marigen, S.A. |
Biotenside esters and phosphatides with vitamin-D and vitamin-E compounds
|
|
ES2136092T3
(es)
|
1991-09-23 |
1999-11-16 |
Medical Res Council |
Procedimientos para la produccion de anticuerpos humanizados.
|
|
US5238922A
(en)
|
1991-09-30 |
1993-08-24 |
Merck & Co., Inc. |
Inhibitors of farnesyl protein transferase
|
|
US5639641A
(en)
|
1992-09-09 |
1997-06-17 |
Immunogen Inc. |
Resurfacing of rodent antibodies
|
|
CA2107644A1
(en)
|
1992-10-28 |
1994-04-29 |
David R. Magnin |
.alpha.-phosphonosulfonae squalene synthetase inhibitors and methd
|
|
US5843941A
(en)
|
1993-05-14 |
1998-12-01 |
Genentech, Inc. |
Ras farnesyl transferase inhibitors
|
|
US5834434A
(en)
|
1993-05-18 |
1998-11-10 |
University Of Pittsburgh |
Inhibitors of farnesyltransferase
|
|
US5602098A
(en)
|
1993-05-18 |
1997-02-11 |
University Of Pittsburgh |
Inhibition of farnesyltransferase
|
|
US5705686A
(en)
|
1993-05-18 |
1998-01-06 |
University Of Pittsburgh |
Inhibition of farnesyl transferase
|
|
US6365588B1
(en)
|
1993-10-15 |
2002-04-02 |
Schering Corporation |
Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
|
|
US6075025A
(en)
|
1993-10-15 |
2000-06-13 |
Schering Corporation |
Tricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
|
|
US5470832A
(en)
|
1994-01-31 |
1995-11-28 |
Merck & Co., Inc. |
Inhibitors of geranylgeranyl-protein transferase
|
|
US5631401A
(en)
|
1994-02-09 |
1997-05-20 |
Abbott Laboratories |
Inhibitors of protein farnesyltransferase and squalene synthase
|
|
US5439918A
(en)
|
1994-03-14 |
1995-08-08 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
US5420334A
(en)
|
1994-04-04 |
1995-05-30 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
US5523430A
(en)
|
1994-04-14 |
1996-06-04 |
Bristol-Myers Squibb Company |
Protein farnesyl transferase inhibitors
|
|
US5510510A
(en)
|
1994-05-10 |
1996-04-23 |
Bristol-Meyers Squibb Company |
Inhibitors of farnesyl protein transferase
|
|
US5447922A
(en)
|
1994-08-24 |
1995-09-05 |
Bristol-Myers Squibb Company |
α-phosphonosulfinic squalene synthetase inhibitors
|
|
US5830868A
(en)
|
1994-09-13 |
1998-11-03 |
Warner-Lambert Company |
Substituted DI- and tripeptide inhibitors of protein: farnesyl transferase
|
|
US5574025A
(en)
|
1994-10-26 |
1996-11-12 |
Merck & Co., Inc. |
Inhibitors of prenyl-protein transferases
|
|
US5786193A
(en)
|
1995-01-11 |
1998-07-28 |
Human Genome Sciences, Inc. |
Human geranylgeranyl pyrophosphate synthethase
|
|
US5801175A
(en)
|
1995-04-07 |
1998-09-01 |
Schering Corporation |
Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
|
|
CA2219361C
(en)
|
1995-04-27 |
2012-02-28 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
|
WO1996034096A1
(en)
|
1995-04-28 |
1996-10-31 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
|
US5756528A
(en)
|
1995-06-06 |
1998-05-26 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
US5618964A
(en)
|
1995-06-07 |
1997-04-08 |
Bristol-Myers Squibb Company |
Prodrug esters of phosphonosulfonate squalene synthetase inhibitors and method
|
|
GB9604311D0
(en)
|
1996-02-29 |
1996-05-01 |
Merck & Co Inc |
Inhibitors of farnesyl-protein transferase
|
|
IT1276162B1
(it)
|
1995-11-23 |
1997-10-27 |
Baldacci Lab Spa |
Geranilgeranil-derivati,procedimento per la loro preparazione e relative composizioni farmaceutiche
|
|
US5874442A
(en)
|
1995-12-22 |
1999-02-23 |
Schering-Plough Corporation |
Tricyclic amides useful for inhibition of G-protein function and for treatment of proliferative disease
|
|
US6011029A
(en)
|
1996-02-26 |
2000-01-04 |
Bristol-Myers Squibb Company |
Inhibitors of farnesyl protein transferase
|
|
US5891889A
(en)
|
1996-04-03 |
1999-04-06 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
US5898031A
(en)
|
1996-06-06 |
1999-04-27 |
Isis Pharmaceuticals, Inc. |
Oligoribonucleotides for cleaving RNA
|
|
US5773455A
(en)
|
1996-06-28 |
1998-06-30 |
Biomeasure, Incorporated |
Inhibitors of prenyl transferases
|
|
US6030982A
(en)
|
1996-09-13 |
2000-02-29 |
Schering Corporationm |
Compounds useful for inhibition of farnesyl protein transferase
|
|
US5994364A
(en)
|
1996-09-13 |
1999-11-30 |
Schering Corporation |
Tricyclic antitumor farnesyl protein transferase inhibitors
|
|
US6083979A
(en)
|
1996-10-09 |
2000-07-04 |
University Of Pittsburgh |
Geranylgeraniol/lovastatin: a novel approach to blocking cancer transformation without cytotoxicity
|
|
US5916771A
(en)
|
1996-10-11 |
1999-06-29 |
Abgenix, Inc. |
Production of a multimeric protein by cell fusion method
|
|
US5929077A
(en)
|
1996-11-08 |
1999-07-27 |
Leftheris; Katerina |
Thioproline-containing inhibitors of farnesyl protein transferase
|
|
EP1972194A1
(en)
|
1996-12-03 |
2008-09-24 |
Amgen Fremont Inc. |
Transgenic mammals having human ig loci including plural vh and vk regions and antibodies produced therefrom
|
|
WO1998046625A1
(en)
|
1997-04-11 |
1998-10-22 |
Warner-Lambert Company |
Dipeptide inhibitors of protein farnesyltransferase
|
|
JP3876002B2
(ja)
|
1997-04-14 |
2007-01-31 |
ミクロメート・アクチエンゲゼルシャフト |
抗ヒト抗原受容体を産生するための斬新な方法およびそれらの使用
|
|
US6051565A
(en)
|
1997-04-26 |
2000-04-18 |
International Phytochemistry Research Labs, Ltd. |
Farnesyl-protein transferase inhibitors
|
|
US6235883B1
(en)
|
1997-05-05 |
2001-05-22 |
Abgenix, Inc. |
Human monoclonal antibodies to epidermal growth factor receptor
|
|
US6358968B1
(en)
|
1997-06-17 |
2002-03-19 |
Schering Corporation |
N-substituted urea inhibitors of farnesyl-protein transferase
|
|
US6239140B1
(en)
|
1997-06-17 |
2001-05-29 |
Schering Corporation |
Compounds useful for inhibition of farnesyl protein transferase
|
|
US6211193B1
(en)
|
1997-06-17 |
2001-04-03 |
Schering Corporation |
Compounds useful for inhibition of farnesyl protein transferase
|
|
US6228865B1
(en)
|
1997-06-17 |
2001-05-08 |
Schering Corporation |
Compounds useful for inhibition of farnesyl protein transferase
|
|
US6218401B1
(en)
|
1997-06-17 |
2001-04-17 |
Schering Corporation |
Phenyl-substituted tricyclic inhibitors of farnesyl-protein transferase
|
|
US6576639B1
(en)
|
1997-06-17 |
2003-06-10 |
Schering Corporation |
Compounds for the inhibition of farnesyl protein transferase
|
|
US6159984A
(en)
|
1997-06-17 |
2000-12-12 |
Schering Corporation |
Farnesyl protein transferase inhibitors
|
|
US6426352B1
(en)
|
1997-06-17 |
2002-07-30 |
Schering Corporation |
Sulfonamide inhibitors of farnesyl-protein transferase
|
|
US6225322B1
(en)
|
1997-06-17 |
2001-05-01 |
Schering Corporation |
Compounds useful for inhibition of farnesyl protein transferase
|
|
TW527355B
(en)
|
1997-07-02 |
2003-04-11 |
Bristol Myers Squibb Co |
Inhibitors of farnesyl protein transferase
|
|
US6387903B1
(en)
|
1997-08-27 |
2002-05-14 |
Merck & Co., Inc. |
Inhibitors of prenyl-protein transferase
|
|
US6458783B1
(en)
|
1997-09-29 |
2002-10-01 |
Bristol-Myers Squibb Company |
Non-imidazole benzodiazepine inhibitors of farnesyl protein transferase
|
|
WO1999026657A1
(en)
|
1997-11-25 |
1999-06-03 |
Musc Foundation For Research Development |
Inhibitors of nitric oxide synthase
|
|
US6267952B1
(en)
|
1998-01-09 |
2001-07-31 |
Geltex Pharmaceuticals, Inc. |
Lipase inhibiting polymers
|
|
US6586461B1
(en)
|
1998-06-16 |
2003-07-01 |
Wayne State University |
Prenyl transferase inhibitors
|
|
ID26987A
(id)
|
1998-07-06 |
2001-02-22 |
Janssen Pharmaceutica Nv |
Inhibitor-inhibitor transferase protein farnesil dengan sifat-sifat peka terhadap sinar radiasi in vivo
|
|
HRP20000904A2
(en)
|
1998-07-06 |
2001-12-31 |
Janssen Pharmaceutica Nv |
Farnesyl protein transferase inhibitors for treating arthropathies
|
|
US6423751B1
(en)
|
1998-07-14 |
2002-07-23 |
The Brigham And Women's Hospital, Inc. |
Upregulation of type III endothelial cell nitric oxide synthase by agents that disrupt actin cytoskeletal organization
|
|
US6539309B1
(en)
|
1998-07-30 |
2003-03-25 |
Schering Corporation |
Crystallizable farnesyl protein transferase compositions, crystals thereby obtained, and methods for use
|
|
DE19835850A1
(de)
|
1998-08-07 |
2000-02-10 |
Basf Ag |
Verwendung von Hemmstoffen der HMG-CoA-Reduktase zur Senkung des Cholesteringehaltes in Geflügelei
|
|
US6156746A
(en)
|
1998-08-25 |
2000-12-05 |
Bristol-Myers Squibb Company |
1,2,5-benzothiadiazepine-1,1-dioxides with n-2 imidazolylalkyl substituents
|
|
KR20010072991A
(ko)
|
1998-08-27 |
2001-07-31 |
실버스타인 아써 에이. |
항암제로서 유용한 알키닐-치환된 퀴놀린-2-온 유도체
|
|
CA2341739C
(en)
|
1998-08-27 |
2005-07-12 |
Pfizer Products Inc. |
Quinolin-2-one derivatives useful as anticancer agents
|
|
US6535820B1
(en)
|
1998-08-28 |
2003-03-18 |
Schering Corporation |
Crystalline farnesyl protein transferase compositions and methods for use
|
|
US6329376B1
(en)
|
1998-10-29 |
2001-12-11 |
Merck & Co., Inc. |
Inhibitors of prenyl-protein transferase
|
|
EP1006113A1
(en)
|
1998-12-02 |
2000-06-07 |
Pfizer Products Inc. |
Derivatives of 2-(2-oxo-ethylidene)-imidazolidin-4-one and their use to inhibit abnormal cell growth
|
|
US6372747B1
(en)
|
1998-12-18 |
2002-04-16 |
Schering Corporation |
Farnesyl protein transferase inhibitors
|
|
US6362188B1
(en)
|
1998-12-18 |
2002-03-26 |
Schering Corporation |
Farnesyl protein transferase inhibitors
|
|
US6432959B1
(en)
|
1998-12-23 |
2002-08-13 |
Schering Corporation |
Inhibitors of farnesyl-protein transferase
|
|
US6191147B1
(en)
|
1998-12-24 |
2001-02-20 |
Ppd Discovery, Inc. |
Pyrazole compounds and uses thereof
|
|
TR200201296T2
(tr)
|
1999-02-11 |
2002-07-22 |
Pfizer Products Inc. |
Antikanser maddeleri olarak faydalı heteroaril-ikame edilmiş kinolin-2-on türevleri
|
|
CA2363169A1
(en)
|
1999-03-03 |
2000-09-08 |
Merck & Co., Inc. |
Inhibitors of prenyl-protein transferase
|
|
US6586447B1
(en)
|
1999-04-01 |
2003-07-01 |
Pfizer Inc |
3,3-disubstituted-oxindole derivatives useful as anticancer agents
|
|
US6316462B1
(en)
|
1999-04-09 |
2001-11-13 |
Schering Corporation |
Methods of inducing cancer cell death and tumor regression
|
|
US6458935B1
(en)
|
1999-06-23 |
2002-10-01 |
Merck & Co., Inc. |
Radiolabeled farnesyl-protein transferase inhibitors
|
|
WO2001005998A1
(en)
|
1999-07-16 |
2001-01-25 |
Human Genome Sciences, Inc. |
Follistatin-3
|
|
US6441017B1
(en)
|
1999-09-09 |
2002-08-27 |
Merck & Co., Inc. |
Inhibitors of prenyl-protein transferase
|
|
ES2212971T3
(es)
|
1999-11-30 |
2004-08-16 |
Pfizer Products Inc. |
Derivados de quinolina utiles para la inhibicion de la farnesil protein transferasa.
|
|
US6403581B1
(en)
|
2000-01-19 |
2002-06-11 |
American Cyanamid Company |
Method of inhibition of farnesyl-protein transferase using substituted benz (cd) indol-2-imine and-amine derivatives
|
|
KR100372911B1
(ko)
|
2000-03-22 |
2003-02-17 |
한국생명공학연구원 |
파네실 전이효소의 저해 활성, 세포 주기의 조절 활성 및신생혈관유도 저해 활성을 갖는 9-아세틸아테미놀라이드화합물, 이의 분리 방법 및 이를 포함하는 약학 조성물
|
|
WO2002044164A1
(en)
|
2000-11-29 |
2002-06-06 |
Schering Corporation |
0ovel farnesyl protein transferase inhibitors
|
|
CN100523215C
(zh)
|
2000-12-01 |
2009-08-05 |
马普科技促进协会 |
介导rna干涉的小rna分子
|
|
EP1857547B2
(en)
|
2002-08-05 |
2020-12-02 |
Silence Therapeutics GmbH |
Further novel forms of interfering RNA molecules
|
|
US6649638B1
(en)
|
2002-08-14 |
2003-11-18 |
Ppd Discovery, Inc. |
Prenylation inhibitors and methods of their synthesis and use
|
|
JP4691041B2
(ja)
*
|
2003-11-20 |
2011-06-01 |
チルドレンズ ホスピタル メディカル センター |
Gtpアーゼ阻害剤および使用方法
|
|
WO2009114725A2
(en)
*
|
2008-03-12 |
2009-09-17 |
Children's Hospital Medical Center |
Mobilization of hematopoietic stem cells
|
|
WO2010010027A1
(en)
*
|
2008-07-23 |
2010-01-28 |
Vib Vzw |
Antifungal compounds
|
|
EP2716292B1
(en)
*
|
2011-05-23 |
2017-09-06 |
ONCO Biomedical Technology (Suzhou) Co., Ltd |
Cdc42 inhibitor and uses thereof
|
|
US9980942B2
(en)
*
|
2012-05-02 |
2018-05-29 |
Children's Hospital Medical Center |
Rejuvenation of precursor cells
|
|
WO2019140300A1
(en)
*
|
2018-01-11 |
2019-07-18 |
Fred Hutchinson Cancer Research Center |
Compositions and methods to promote thymic regeneration
|
|
WO2021011800A1
(en)
*
|
2019-07-17 |
2021-01-21 |
Children's Hospital Medical Center |
Method of treating neoplastic diseases with a cdc42-specific inhibitor
|